Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.47 |
| ▸ | BRD2 | P25440 | 2/20 | 0.47 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.47 |
| ▸ | BRDT | Q58F21 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13701807 | 0.88 | BRD4 (0.45) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701808 | 0.85 | BRD4 (0.45) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701817 | 0.83 | ALDH1A1 (0.45) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701812 | 0.82 | BRD4 (0.49) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701759 | 0.82 | EPHX2 (0.46) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701646 | 0.82 | EPHX2 (0.59) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701742 | 0.82 | LMNA (0.44) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701796 | 0.82 | MAPT (0.42) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701838 | 0.82 | HTT (0.46) | BRD4BRD2BRD3BRDTLMNA | |
| SCHEMBL13701709 | 0.81 | BRD4 (0.42) | BRD4BRD2BRD3BRDTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090227588-A1 | Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors | FLECK ROMAN WOLFGANG | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227588-A1 | Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors | EPHX1, EPHX2, EPX | BRD4 2517/4885BRD2 3424/4885BRD3 2358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.